INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 242 filers reported holding INARI MED INC in Q3 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,008,692 | +23.4% | 61,295 | +16.5% | 0.00% | 0.0% |
| Q2 2023 | $3,248,635 | 0.0% | 52,618 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,248,635 | +5.6% | 52,618 | +8.7% | 0.00% | 0.0% |
| Q4 2022 | $3,076,812 | -99.9% | 48,408 | +7.1% | 0.00% | 0.0% |
| Q3 2022 | $3,284,563,000 | -7.8% | 45,217 | -13.7% | 0.00% | 0.0% |
| Q2 2022 | $3,564,102,000 | +31.4% | 52,421 | +75.2% | 0.00% | +100.0% |
| Q1 2022 | $2,711,859,000 | +15.6% | 29,919 | +16.4% | 0.00% | 0.0% |
| Q4 2021 | $2,345,274,000 | +18.2% | 25,696 | +5.1% | 0.00% | 0.0% |
| Q3 2021 | $1,983,463,000 | +10.6% | 24,457 | +27.2% | 0.00% | 0.0% |
| Q2 2021 | $1,793,682,000 | +13.6% | 19,229 | +30.3% | 0.00% | 0.0% |
| Q1 2021 | $1,579,213,000 | +376.1% | 14,759 | +288.4% | 0.00% | – |
| Q4 2020 | $331,702,000 | -54.3% | 3,800 | -74.7% | 0.00% | – |
| Q2 2020 | $726,600,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |